Full Text View
Tabular View
No Study Results Posted
Related Studies
Dry Eye in Women With Turner Syndrome and Women With Premature Ovarian Failure
The recruitment status of this study is unknown because the information has not been verified recently.
Verified October 2009 by National Institutes of Health Clinical Center (CC).   Recruitment status was  Recruiting

First Received on May 9, 2007.   Last Updated on December 21, 2011   History of Changes
Sponsor: National Eye Institute (NEI)
Information provided by: National Institutes of Health Clinical Center (CC)
ClinicalTrials.gov Identifier: NCT00471731
  Purpose

Women with premature ovarian failure (POF) are at risk for dry eye. In addition, some women with Turner syndrome (TS) report dry eye symptoms. This study will determine how many women with TS have dry eye, compared to women with POF and women without these conditions.

Females 16 years of age and older with TS, POF, or neither of these conditions may be eligible for this study. Participants undergo the following tests and procedures:

  • Medical history: Subjects are asked about their current and previous medical conditions and treatments they have had in the past. They complete forms with information about how their eyes feel and if dry eye has bothered them.
  • Assessment of tears and eye surface: The amount of tears the eyes can produce is measured by placing a small piece of sterile paper in the corner of the eye for 5 minutes. Orange and green dyes are also placed in the eyes to determine the health of the surface of the eye.
  • Eye examination: Visual acuity (the ability to see the vision chart) and eye pressure (fluid pressure in the eye) are measured. Pupils and eye movements are examined. The structures inside the eye are examined through a microscope. The lens and retina (back of the eye) are examined after drops have been placed in the eyes to widen the pupils. The retina is examined with an ophthalmoscope (instrument with a strong light and magnifying lens).
  • Blood drawing: Blood samples are drawn through a needle in the arm to test for the level of sex hormones.
  • Conjunctival swab and tear fluid collection: A small sample of tears may be collected in a small tube to study their consistency and makeup. The top layer of cells from the surface of one eye may be removed with a swab or filter paper for study.

Condition
Turner Syndrome
Ovarian Failure, Premature
Sex Chromosome Aberrations
Menopause
Perimenopause

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: Ocular Impact of X Chromosome Karyotype and Sex Hormones in Turner Syndrome and Premature Ovarian Failure

Resource links provided by NLM:

Genetics Home Reference related topics: 17q21.31 microdeletion syndrome persistent Müllerian duct syndrome tetrasomy 18p Turner syndrome
MedlinePlus related topics: Menopause Premature Ovarian Failure Turner Syndrome
U.S. FDA Resources

Further study details as provided by National Institutes of Health Clinical Center (CC):

Estimated Enrollment: 180
Study Start Date: May 2007
Detailed Description:

Premature ovarian failure (POF) is known to be associated with an increased risk of ocular surface disease (dry eye), likely due to the reduction of both estrogens and androgens seen in this condition. From preliminary data, we suspect that women with Turners syndrome (45, XO), a genetic abnormality that affects sex hormone levels, are also at increased risk of ocular surface disease. Comparing POF and TS women may allow us to distinguish different mechanisms for ocular surface disease, due to the different etiologies of hormonal (estrogen and androgen) alterations posed by POF and TS.

  Eligibility

Ages Eligible for Study:   16 Years and older
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Criteria

  • INCLUSION CRITERIA:

    1. Ability to understand and give informed consent.
    2. Meet the diagnostic criteria for TS (45, X0) or premature ovarian failure OR age matched control for study participant with TS or POF.
    3. For non Turner syndrome subjects only - Negative pregnancy test or post menopausal status for greater than or equal to 1 year.
    4. Karyotype of XO for TS subjects or XX for POF and age matched control subjects.

EXCLUSION CRITERIA:

  1. Persons less than 16 years old.
  2. Persons with ophthalmic diseases associated with ocular surface disease.
  3. Hyperprolactinemia.
  4. Cushing's syndrome.
  5. Other endocrine disorders which impact sex steroid hormones.
  6. AIDS
  7. Pregnancy or lactation.
  8. For age matched control population ONLY- oral contraceptives or menopausal hormone therapy or any medications which alter sex hormone levels in the blood.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00471731

Contacts
Contact: Patient Recruitment and Public Liaison Office (800) 411-1222 prpl@mail.cc.nih.gov
Contact: TTY 1-866-411-1010

Locations
United States, Maryland
National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting
Bethesda, Maryland, United States, 20892
Sub-Investigator: Patient Recruitment and Public Liaison Office (PRPL) For more information at the NIH Clinical Center contact            
Sponsors and Collaborators
National Eye Institute (NEI)
  More Information

Additional Information:
NIH Clinical Center Detailed Web Page  This link exits the ClinicalTrials.gov site

Publications:
Smith JA, Vitale S, Reed GF, Grieshaber SA, Goodman LA, Vanderhoof VH, Calis KA, Nelson LM. Dry eye signs and symptoms in women with premature ovarian failure. Arch Ophthalmol. 2004 Feb;122(2):151-6.
Schaumberg DA, Buring JE, Sullivan DA, Dana MR. Hormone replacement therapy and dry eye syndrome. JAMA. 2001 Nov 7;286(17):2114-9.
Coulam CB, Adamson SC, Annegers JF. Incidence of premature ovarian failure. Obstet Gynecol. 1986 Apr;67(4):604-6.

ClinicalTrials.gov Identifier: NCT00471731     History of Changes
Other Study ID Numbers: 070145, 07-EI-0145
Study First Received: May 9, 2007
Last Updated: December 21, 2011
Health Authority: United States: Federal Government

Keywords provided by National Institutes of Health Clinical Center (CC):
Ocular Surface Disease
Imprinting
Eye Abnormalities
Ovarian Insufficiency
Women's Eye Health and Disease
Turner Syndrome
 TS
Premature Ovarian Failure
POF
Healthy Volunteer
HV

Additional relevant MeSH terms:
Chromosome Aberrations
Chromosome Disorders
Menopause, Premature
Primary Ovarian Insufficiency
Sex Chromosome Aberrations
Turner Syndrome
Gonadal Dysgenesis
Pathologic Processes
Congenital Abnormalities
Genetic Diseases, Inborn
Ovarian Diseases
Adnexal Diseases
 Genital Diseases, Female
Gonadal Disorders
Endocrine System Diseases
Disorders of Sex Development
Urogenital Abnormalities
Sex Chromosome Disorders of Sex Development
Heart Defects, Congenital
Cardiovascular Abnormalities
Cardiovascular Diseases
Heart Diseases
Sex Chromosome Disorders

ClinicalTrials.gov processed this record on February 09, 2012



Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services